IMGN logo

ImmunoGen (IMGN) Total Assets

Annual Total Assets

$348.94 M
-$176.83 M-33.63%

December 31, 2022


Summary


Performance

IMGN Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNbalance sheetmetrics:

Quarterly Total Assets

$822.10 M
+$107.77 M+15.09%

September 30, 2023


Summary


Performance

IMGN Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

IMGN Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.6%+129.1%
3 y3 years+48.3%+231.6%
5 y5 years+18.4%+141.9%

IMGN Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-33.6%at lowat high-64.9%
5 y5-year-33.6%-32.6%at high-71.4%
alltimeall time-33.6%-98.3%at high-99.3%

ImmunoGen Total Assets History

DateAnnualQuarterly
Sep 2023
-
$822.10 M(+15.1%)
Jun 2023
-
$714.33 M(+147.7%)
Mar 2023
-
$288.35 M(-17.4%)
Dec 2022
$348.94 M(-33.6%)
$348.94 M(-2.7%)
Sep 2022
-
$358.80 M(-15.0%)
Jun 2022
-
$422.30 M(-12.3%)
Mar 2022
-
$481.71 M(-8.4%)
Dec 2021
$525.76 M(+48.1%)
$525.76 M(+77.1%)
Sep 2021
-
$296.80 M(-1.5%)
Jun 2021
-
$301.45 M(-12.9%)
Mar 2021
-
$345.96 M(-2.6%)
Dec 2020
$355.07 M(+50.9%)
$355.07 M(+43.2%)
Sep 2020
-
$247.95 M(-8.1%)
Jun 2020
-
$269.73 M(-9.7%)
Mar 2020
-
$298.81 M(+27.0%)
Dec 2019
$235.26 M(-20.4%)
$235.26 M(-7.4%)
Sep 2019
-
$254.14 M(-11.7%)
Jun 2019
-
$287.67 M(-11.2%)
Mar 2019
-
$323.93 M(+9.7%)
Dec 2018
$295.38 M(+0.2%)
$295.38 M(-13.1%)
Sep 2018
-
$339.86 M(-10.8%)
Jun 2018
-
$381.08 M(+43.8%)
Mar 2018
-
$264.96 M(-10.1%)
Dec 2017
$294.68 M(+48.2%)
$294.68 M(+30.6%)
Sep 2017
-
$225.69 M(+24.4%)
Jun 2017
-
$181.38 M(+11.1%)
Mar 2017
-
$163.32 M(-29.4%)
Dec 2016
$198.86 M(-28.8%)
-
Sep 2016
-
$231.35 M(-17.2%)
Jun 2016
$279.24 M(-9.4%)
$279.24 M(+25.6%)
Mar 2016
-
$222.35 M(-11.6%)
Dec 2015
-
$251.58 M(-11.9%)
Sep 2015
-
$285.58 M(-7.4%)
Jun 2015
$308.25 M(+86.5%)
$308.25 M(+130.4%)
Mar 2015
-
$133.80 M(+4.1%)
Dec 2014
-
$128.54 M(-10.2%)
Sep 2014
-
$143.11 M(-13.4%)
Jun 2014
$165.32 M(-22.6%)
$165.32 M(-11.4%)
Mar 2014
-
$186.69 M(-7.8%)
Dec 2013
-
$202.52 M(+1.2%)
Sep 2013
-
$200.02 M(-6.4%)
Jun 2013
$213.60 M(+18.5%)
$213.60 M(-6.6%)
Mar 2013
-
$228.68 M(-0.9%)
Dec 2012
-
$230.84 M(-8.6%)
Sep 2012
-
$252.67 M(+40.1%)
Jun 2012
$180.31 M(-17.2%)
$180.31 M(-8.2%)
Mar 2012
-
$196.33 M(-5.7%)
Dec 2011
-
$208.22 M(+4.6%)
Sep 2011
-
$199.10 M(-8.5%)
Jun 2011
$217.64 M(+58.6%)
$217.64 M(+52.9%)
Mar 2011
-
$142.32 M(-7.5%)
Dec 2010
-
$153.81 M(+27.4%)
Sep 2010
-
$120.76 M(-12.0%)
Jun 2010
$137.21 M(+36.2%)
$137.21 M(+98.3%)
Mar 2010
-
$69.20 M(-14.1%)
Dec 2009
-
$80.54 M(-9.4%)
Sep 2009
-
$88.92 M(-11.7%)
Jun 2009
$100.70 M(+20.8%)
$100.70 M(+36.7%)
Mar 2009
-
$73.65 M(-6.2%)
Dec 2008
-
$78.53 M(+0.1%)
Sep 2008
-
$78.42 M(-5.9%)
Jun 2008
$83.34 M(+3.6%)
$83.34 M(+1.7%)
Mar 2008
-
$81.92 M(+2.7%)
Dec 2007
-
$79.77 M(+0.8%)
Sep 2007
-
$79.16 M(-1.6%)
Jun 2007
$80.42 M
$80.42 M(-5.3%)
Mar 2007
-
$84.89 M(-3.2%)
DateAnnualQuarterly
Dec 2006
-
$87.73 M(-2.5%)
Sep 2006
-
$90.02 M(-4.4%)
Jun 2006
$94.13 M(-14.5%)
$94.13 M(-8.4%)
Mar 2006
-
$102.74 M(-1.6%)
Dec 2005
-
$104.45 M(-1.7%)
Sep 2005
-
$106.26 M(-3.5%)
Jun 2005
$110.13 M(-10.2%)
$110.13 M(-3.2%)
Mar 2005
-
$113.77 M(-1.4%)
Dec 2004
-
$115.36 M(-2.4%)
Sep 2004
-
$118.25 M(-3.6%)
Jun 2004
$122.63 M(+3.9%)
$122.63 M(-2.8%)
Mar 2004
-
$126.11 M(+1.7%)
Dec 2003
-
$124.06 M(-1.3%)
Sep 2003
-
$125.68 M(+6.5%)
Jun 2003
$118.03 M(-22.4%)
$118.03 M(-6.6%)
Mar 2003
-
$126.35 M(-8.2%)
Dec 2002
-
$137.68 M(-5.8%)
Sep 2002
-
$146.21 M(-3.9%)
Jun 2002
$152.16 M(-4.4%)
$152.16 M(-2.9%)
Mar 2002
-
$156.65 M(-4.2%)
Dec 2001
-
$163.51 M(+0.1%)
Sep 2001
-
$163.37 M(+2.6%)
Jun 2001
$159.16 M(+722.8%)
$159.16 M(-1.7%)
Mar 2001
-
$161.89 M(+0.3%)
Dec 2000
-
$161.47 M(+326.3%)
Sep 2000
-
$37.88 M(+95.8%)
Jun 2000
$19.34 M(+168.7%)
$19.34 M(+22.5%)
Mar 2000
-
$15.79 M(+12.8%)
Dec 1999
-
$14.00 M(+14.8%)
Sep 1999
-
$12.20 M(+69.4%)
Jun 1999
$7.20 M(+22.0%)
$7.20 M(+20.0%)
Mar 1999
-
$6.00 M(+7.1%)
Dec 1998
-
$5.60 M(-12.5%)
Sep 1998
-
$6.40 M(+8.5%)
Jun 1998
$5.90 M(-6.3%)
$5.90 M(-9.2%)
Mar 1998
-
$6.50 M(-7.1%)
Dec 1997
-
$7.00 M(+2.9%)
Sep 1997
-
$6.80 M(+7.9%)
Jun 1997
$6.30 M(-25.9%)
$6.30 M(-13.7%)
Mar 1997
-
$7.30 M(+5.8%)
Dec 1996
-
$6.90 M(+9.5%)
Sep 1996
-
$6.30 M(-25.9%)
Jun 1996
$8.50 M(-50.0%)
$8.50 M(-5.6%)
Mar 1996
-
$9.00 M(+4.7%)
Dec 1995
-
$8.60 M(-49.4%)
Sep 1995
-
$17.00 M(0.0%)
Jun 1995
$17.00 M(-55.7%)
$17.00 M(-18.7%)
Mar 1995
-
$20.90 M(-34.1%)
Sep 1994
-
$31.70 M(-17.4%)
Jun 1994
$38.40 M(-17.4%)
$38.40 M(-13.9%)
Mar 1994
-
$44.60 M(+30.0%)
Dec 1993
-
$34.30 M(-14.0%)
Sep 1993
-
$39.90 M(-14.2%)
Jun 1993
$46.50 M(-25.0%)
$46.50 M(-6.1%)
Mar 1993
-
$49.50 M(-7.0%)
Dec 1992
-
$53.20 M(-7.6%)
Sep 1992
-
$57.60 M(-7.1%)
Jun 1992
$62.00 M(+39.6%)
$62.00 M(-5.8%)
Mar 1992
-
$65.80 M(+62.1%)
Sep 1991
-
$40.60 M(-8.6%)
Jun 1991
$44.40 M(+194.0%)
$44.40 M(+0.2%)
Mar 1991
-
$44.30 M(+278.6%)
Dec 1990
-
$11.70 M(-20.4%)
Sep 1990
-
$14.70 M(-2.6%)
Jun 1990
$15.10 M(+65.9%)
$15.10 M(-12.7%)
Mar 1990
-
$17.30 M(+127.6%)
Sep 1989
-
$7.60 M(-16.5%)
Jun 1989
$9.10 M
$9.10 M

FAQ

  • What is ImmunoGen annual total assets?
  • What is the all time high annual total assets for ImmunoGen?
  • What is ImmunoGen annual total assets year-on-year change?
  • What is ImmunoGen quarterly total assets?
  • What is the all time high quarterly total assets for ImmunoGen?
  • What is ImmunoGen quarterly total assets year-on-year change?

What is ImmunoGen annual total assets?

The current annual total assets of IMGN is $348.94 M

What is the all time high annual total assets for ImmunoGen?

ImmunoGen all-time high annual total assets is $525.76 M

What is ImmunoGen annual total assets year-on-year change?

Over the past year, IMGN annual total assets has changed by -$176.83 M (-33.63%)

What is ImmunoGen quarterly total assets?

The current quarterly total assets of IMGN is $822.10 M

What is the all time high quarterly total assets for ImmunoGen?

ImmunoGen all-time high quarterly total assets is $822.10 M

What is ImmunoGen quarterly total assets year-on-year change?

Over the past year, IMGN quarterly total assets has changed by +$463.30 M (+129.13%)